Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 25,400
+220 (0.87%)
Apr 27, 2026, 3:29 PM IST
Abbott India Market Cap
Abbott India has a market cap or net worth of 535.45 billion as of April 27, 2026. Its market cap has decreased by -14.79% in one year.
Market Cap
535.45B
Enterprise Value
513.85B
Revenue
68.24B
Ranking
n/a
PE Ratio
35.13
Stock Price
25,400.00
Market Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 535.45B, an increase of 11,127.05%. That is a compound annual growth rate of 21.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 535.45B | -13.32% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.05T |
| Mankind Pharma | 936.05B |
| Zydus Lifesciences | 933.18B |
| Aurobindo Pharma | 821.14B |
| Glenmark Pharmaceuticals | 648.92B |
| Alkem Laboratories | 625.92B |
| Laurus Labs | 601.10B |
| Ipca Laboratories | 394.74B |